AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 81 filers reported holding AUDENTES THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $4,751,000 | +66.4% | 120,000 | +26.3% | 0.54% | +25.9% |
| Q1 2018 | $2,855,000 | -3.8% | 95,000 | 0.0% | 0.43% | +24.4% |
| Q4 2017 | $2,969,000 | +11.6% | 95,000 | 0.0% | 0.35% | -8.4% |
| Q3 2017 | $2,661,000 | -7.3% | 95,000 | -36.7% | 0.38% | -22.1% |
| Q2 2017 | $2,870,000 | +7.4% | 150,000 | 0.0% | 0.49% | +12.2% |
| Q3 2016 | $2,672,000 | – | 150,000 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,204,615 | $36,198,681,000 | 11.58% |
| Sofinnova Investments, Inc. | 1,380,303 | $41,478,000 | 7.13% |
| Casdin Capital, LLC | 450,000 | $13,523,000 | 2.38% |
| Foresite Capital Management III, LLC | 315,331 | $9,476,000 | 2.06% |
| Opaleye Management Inc. | 190,000 | $5,709,000 | 1.63% |
| Redmile Group, LLC | 1,308,526 | $39,321,000 | 1.52% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,384,470 | $41,603,000 | 1.44% |
| Orbimed Advisors | 3,522,100 | $105,839,000 | 1.31% |
| Rock Springs Capital Management LP | 565,000 | $16,978,000 | 0.72% |
| Cormorant Asset Management, LP | 322,945 | $9,704,000 | 0.72% |